Suppr超能文献

脂质体内部核心的凝胶化作为一种稳定化和改良药物传递的策略 II. 体外释放实验的理论分析和建模。

Gelation of the internal core of liposomes as a strategy for stabilization and modified drug delivery II. Theoretical analysis and modelling of in-vitro release experiments.

机构信息

Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy.

Dipartimento di Chimica e Tecnologie del Farmaco, Sapienza Università di Roma, Piazzale Aldo Moro 5, 00185 Rome, Italy.

出版信息

Int J Pharm. 2020 Jul 30;585:119471. doi: 10.1016/j.ijpharm.2020.119471. Epub 2020 May 29.

Abstract

PEG-DMA was incorporated in unilamellar liposomes. PEG-DMA crosslinking by photo-induced radical reaction transforms the liquid aqueous core of the liposome into a hydrogel. The molecular weight of PEG-DMA significantly influences both structural and release properties of these hybrid nanosystems, by affecting both membrane permeability and diffusional properties of the inner core. Release studies of 5-(6) carboxyfluorescein from Conventional Liposomes (CL) and Gel-in-Liposome (GiL) systems were carried out in a vertical Franz Diffusion Cell. A detailed transport model is proposed, aimed at describing the entire drug diffusive pathway from the vesicles' inner core, through the double-layer membrane, into the buffer solution in the donor chamber of the Franz Cell and from there to the receptor chamber, where withdrawals are performed to evaluate the released drug concentration. The model permits to give a quantitative estimate of the diffusional resistances offered by the inner core (liquid or gelled) and by the double-layer membrane for CLs and different GiLs systems. The theoretical analysis of experimental release data strongly supports the basic assumption that, by varying the molecular weight of PEG-DMA, a different arrangement of the polymer within the liposomal structure and a different interaction with the membrane occur. PEG-DMA decreases the transport resistance of the double layer membrane with respect to CLs, while PEG-DMA plays the opposite role. After gelation of the internal core, the diffusional resistance to drug transport inside GiLs becomes controlling, thus significantly slowing down drug release from these systems. Therefore, the combination of PEG-DMA with phospholipid vesicles appears an interesting strategy to develop sustained drug delivery systems.

摘要

聚乙二醇-二甲基丙烯酰胺(PEG-DMA)被掺入单层脂质体中。通过光诱导自由基反应交联 PEG-DMA 将脂质体的液态水核转化为水凝胶。PEG-DMA 的分子量显著影响这些混合纳米系统的结构和释放特性,这是通过影响膜通透性和内芯的扩散性质来实现的。在垂直 Franz 扩散池(Franz Diffusion Cell)中,对常规脂质体(CL)和凝胶在脂质体(GiL)系统中 5-(6)羧基荧光素的释放进行了研究。提出了一个详细的传输模型,旨在描述药物从囊泡的内核通过双层膜扩散到 Franz 池供体腔中的缓冲溶液,以及从那里到受体腔的整个扩散途径,在受体腔中进行提取以评估释放的药物浓度。该模型可以定量估计内核(液态或凝胶态)和双层膜对 CL 和不同 GiL 系统的扩散阻力。对实验释放数据的理论分析强烈支持了基本假设,即通过改变 PEG-DMA 的分子量,聚合物在脂质体结构中的排列方式和与膜的相互作用方式会发生变化。PEG-DMA 降低了双层膜的传输阻力,与 CL 相比,而 PEG-DMA 则起到相反的作用。内部核心凝胶化后,药物在 GiLs 中的内部传输扩散阻力成为控制因素,从而显著减缓这些系统中药物的释放。因此,PEG-DMA 与磷脂囊泡的结合似乎是开发持续药物递送系统的一种有趣策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验